Immatics (IMTX) Operating Expenses (2019 - 2025)
Immatics' (IMTX) quarterly Operating Expenses came in at -$73.7 million in Q4 2025, down 24.54% year-on-year from -$97.7 million in Q4 2024, and down 5.32% quarter-over-quarter from -$70.0 million in Q3 2025.
Immatics (IMTX) Operating Expenses (2019 - 2025) Analysis & Trends
Immatics has disclosed Operating Expenses across 7 years of filings, most recently posting -$73.7 million for Q4 2025.
- Operating Expenses for Q4 2025 came in at -$73.7 million, down 24.54% year-over-year; the trailing twelve-month figure through Dec 2025 was -$266.0 million (down 26.34% YoY), and the FY2025 annual result was -$265.5 million, down 27.73% from the prior year.
- Operating Expenses came in at -$73.7 million for Q4 2025 at Immatics, down from -$70.0 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of -$34.5 million in Q2 2021 to a low of -$73.7 million in Q4 2025.
- The 5-year median for Operating Expenses is -$41.4 million (2023), against an average of -$47.0 million.
- Across the five-year window, Operating Expenses plunged 86.6% in 2021 and dropped 1.74% in 2022, its largest moves.
- Immatics' Operating Expenses stood at -$36.4 million in 2021, then dropped by 5.41% to -$38.3 million in 2022, then slipped by 22.44% to -$47.0 million in 2023, then decreased by 26.02% to -$59.2 million in 2024, then declined by 24.54% to -$73.7 million in 2025.
- The last three Operating Expenses figures came in at -$73.7 million (Q4 2025), -$70.0 million (Q3 2025), and -$65.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -67.40 Mn |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | -73.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -73.69 Mn |
| Sep 30, 2025 | -69.97 Mn |
| Jun 30, 2025 | -65.52 Mn |
| Mar 31, 2025 | -56.78 Mn |
| Dec 31, 2024 | -59.17 Mn |
| Sep 30, 2024 | -54.98 Mn |
| Jun 30, 2024 | -48.83 Mn |
| Mar 31, 2024 | -47.53 Mn |
| Dec 31, 2023 | -46.95 Mn |
| Sep 30, 2023 | -42.87 Mn |
| Jun 30, 2023 | -39.94 Mn |
| Mar 31, 2023 | -39.89 Mn |
| Dec 31, 2022 | -38.35 Mn |
| Sep 30, 2022 | -37.30 Mn |
| Jun 30, 2022 | -36.17 Mn |
| Mar 31, 2022 | -38.63 Mn |
| Dec 31, 2021 | -36.38 Mn |
| Sep 30, 2021 | -34.78 Mn |
| Jun 30, 2021 | -34.46 Mn |
| Mar 31, 2021 | -37.97 Mn |